Michael Kyriakides
Directeur/Membre du Conseil chez Purespring Therapeutics Ltd.
Profil
Michael Kyriakides is an Investment Partner of Syncona Investment Management Ltd.
He works closely with Syncona portfolio companies Freeline Therapeutics and Clade Therapeutics.
Previously, Michael was a member of the Life Sciences team at L.E.K.
Consulting, where he worked in projects for pharmaceutical, biotech and private equity clients.
Prior to joining L.E.K.
Consulting, he was a clinical project and NMR manager in the Faculty of Medicine at Imperial College London.
Michael obtained his doctorate degree in toxicology and metabolic profiling at Imperial College London.
Syncona portfolio companies
Freeline Therapeutics
Clade Therapeutics (Board observer)
Purespring Therapeutics (Board member)
Postes actifs de Michael Kyriakides
| Sociétés | Poste | Début |
|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/08/2018 |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/04/2022 |
Formation de Michael Kyriakides
| Imperial College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Commercial Services |
